Cannabotech Ltd. Logo

Cannabotech Ltd.

Develops therapies by integrating cannabinoids and medicinal mushroom extracts.

CNTC | TA

Overview

Corporate Details

ISIN(s):
IL0011769085
LEI:
Country:
Israel
Address:
3 Arik Einstein, 4659071 Herzliya

Description

Cannabotech Ltd. is a biomedical company developing therapeutic solutions by integrating cannabinoids and medicinal mushroom extracts. The company's activities encompass both pharmaceutical development and consumer wellness. Its pharmaceutical research focuses on treatments for oncology and inflammatory diseases. Concurrently, Cannabotech markets a consumer product line based on its proprietary M2CBD formula, which synergistically combines highly bioavailable CBD with patented functional mushroom varieties. These supplements and topical products are formulated to support immunity, sleep, and stress management, promoting a preventative approach to health and well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-03 16:01
Changes in the company's name and security's name, effective as of December 7, …
English PDF 125.1 KB
2025-02-10 17:47
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) PDF 90.8 KB
2025-01-09 10:41
Capital consolidation 10:1, There will be no trading in the company's shares on…
Hebrew (modern) PDF 77.6 KB
2024-11-12 18:33
Trading in the company's shares (ISIN IL0011769085) will be renewed on Thursday…
Hebrew (modern) PDF 158.8 KB
2024-10-01 10:13
Suspension due to failure in publication of financial reports
Hebrew (modern) PDF 79.6 KB
2024-09-29 17:58
CANNABOTECH– Appointment of a Market Maker
Hebrew (modern) PDF 151.8 KB
2024-09-23 19:44
Failure in publishing financial reports-Notification
Hebrew (modern) PDF 127.4 KB
2024-09-02 15:06
Discontinuation of Market Making
Hebrew (modern) PDF 92.1 KB
2022-01-11 15:43
Opening of Trading on January 12 2022- CANNABOTECH W3
Hebrew (modern) PDF 253.5 KB
2022-01-10 10:54
Identifying Details of New Security-CANNABOTECH W3
Hebrew (modern) PDF 174.6 KB
2021-09-13 19:45
will not be added TA-Tech Elite Index
Hebrew (modern) PDF 82.9 KB
2021-07-25 18:17
Fast Track to TA-Tech Elite Index as on October 7th, 2021 at the end of the tra…
Hebrew (modern) PDF 162.5 KB
2021-07-25 16:07
Appointment of a Market Maker
Hebrew (modern) PDF 210.0 KB
2021-07-21 18:34
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) PDF 244.6 KB
2021-06-15 16:11
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) PDF 155.0 KB

Automate Your Workflow. Get a real-time feed of all Cannabotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cannabotech Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cannabotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.